Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of January 2024
Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of Jan-05-2024
-
World Rank (Jan-05-2024)6,615Market Cap (Jan-05-2024)1.562 Billion USDWorld Rank (Jul-30-2023)7,238Market Cap (Jul-30-2023)1.379 Billion USDWorld Rank (Dec-25-2022)7,898Market Cap (Dec-25-2022)1.107 Billion USDWorld Rank (Jan-07-2022)6,638Market Cap (Jan-07-2022)1.83 Billion USDAnnual Revenue in USD561 Million USDAnnual Net Income in USD58 Million USDAnnual Results for Period EndingMar-2022 ending yearCompany ProfileTaro Pharmaceutical Industries is a Research Based International Pharmaceutical company. The headquarters is in USA.Company Website
-
Kiniksa Pharmaceuticals
World Rank (Jan-05-2024)7,059Market Cap (Jan-05-2024)1.405 Billion USDWorld Rank (Jul-30-2023)7,387Market Cap (Jul-30-2023)1.325 Billion USDWorld Rank (Dec-25-2022)8,029Market Cap (Dec-25-2022)1.075 Billion USDWorld Rank (Jan-07-2022)10,948Market Cap (Jan-07-2022)0.76 Billion USDAnnual Revenue in USD38 Million USDAnnual Net Income in USD-157 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany Website -
Biohaven Pharmaceutical Holding Company
World Rank (Jan-05-2024)3,972Market Cap (Jan-05-2024)3.399 Billion USDWorld Rank (Jul-30-2023)7,470Market Cap (Jul-30-2023)1.300 Billion USDWorld Rank (Dec-25-2022)8,706Market Cap (Dec-25-2022)0.934 Billion USDWorld Rank (Jan-07-2022)2,147Market Cap (Jan-07-2022)8.44 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-570 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileBiohaven Pharmaceutical Holding Company is a Clinical Stage Biopharmaceutical company. It portfolio is comprised of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases including rare disorders. The company is rapidly progressing multiple compounds in clinical trials across three platforms they are calcitonin gene related peptide receptor antagonism, glutamate modulation and myeloperoxidase inhibition. The headquarters is in USA.
Company Website -
Travere Therapeutics Inc.
World Rank (Jan-05-2024)10,719Market Cap (Jan-05-2024)0.683 Billion USDWorld Rank (Jul-30-2023)7,507Market Cap (Jul-30-2023)1.287 Billion USDWorld Rank (Dec-25-2022)7,234Market Cap (Dec-25-2022)1.285 Billion USDWorld Rank (Jan-07-2022)6,953Market Cap (Jan-07-2022)1.70 Billion USDAnnual Revenue in USD212 Million USDAnnual Net Income in USD-278 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileTravere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life changing therapies to people living with rare disease. The headquarters is in USA.
Facts About CompanyTravere Therapeutics Annual Total Revenue for year ending Dec-2022 was 212 million USD and and Net loss for year ending Dec-2022 was -278 million USD.
Travere Therapeutics Annual Total Revenue for year ending Dec-2021 was 227 million USD and and Net loss for year ending Dec-2021 was -180 million USD.
As on 2022, Travere Therapeutics has 462 employees.
Company Website -
Usana Health Sciences
World Rank (Jan-05-2024)8,606Market Cap (Jan-05-2024)0.996 Billion USDWorld Rank (Jul-30-2023)7,626Market Cap (Jul-30-2023)1.257 Billion USDWorld Rank (Dec-25-2022)8,169Market Cap (Dec-25-2022)1.045 Billion USDWorld Rank (Jan-07-2022)6,351Market Cap (Jan-07-2022)1.97 Billion USDAnnual Revenue in USD998 Million USDAnnual Net Income in USD69 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileUsana Health Sciences is Internationally Recognized for High Quality, Science Based Nutritional Supplements, Healthy Foods, Personal Care Products and Skincare Products company. The company is supporting a holistically healthy lifestyle which includes eight main tenets they are a whole food based, low glycemic diet, proper hydration, quality sleep, stress management, regular exercise, regular and consistent skincare, mindfulness and high quality vitamin and mineral supplementation. The headquarters is in USA.Company Website -
Keros Therapeutics Inc.
World Rank (Jan-05-2024)6,873Market Cap (Jan-05-2024)1.464 Billion USDWorld Rank (Jul-30-2023)7,679Market Cap (Jul-30-2023)1.242 Billion USDWorld Rank (Dec-25-2022)7,230Market Cap (Dec-25-2022)1.286 Billion USDWorld Rank (Jan-07-2022)8,347Market Cap (Jan-07-2022)1.24 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-104 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileKeros Therapeutics is a Clinical Stage Biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics by leveraging deep understanding of specifically hematopoiesis and musculoskeletal systems. The company annual revenue is 10 million USD and 23 employees as on 2019. The headquarters is in USA.Company Website -
IDEAYA Biosciences Inc.
World Rank (Jan-05-2024)5,323Market Cap (Jan-05-2024)2.231 Billion USDWorld Rank (Jul-30-2023)7,684Market Cap (Jul-30-2023)1.241 Billion USDWorld Rank (Dec-25-2022)9,463Market Cap (Dec-25-2022)0.819 Billion USDWorld Rank (Jan-07-2022)11,494Market Cap (Jan-07-2022)0.69 Billion USDAnnual Revenue in USD51 Million USDAnnual Net Income in USD-59 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileIDEAYA is a synthetic lethality focused precision medicine oncology company developments and discovery of targeted therapeutics for patient populations selected using molecular diagnostics. The headquarters is in USA.
Facts About CompanyIDEAYA Annual Total Revenue for year ending Dec-2022 was 50 million USD and and Net loss for year ending Dec-2022 was -58 million USD.
IDEAYA Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -50 million USD.
As on 2022, IDEAYA has 103 employees.
Company Website -
Verve Therapeutics Inc.
World Rank (Jan-05-2024)8,130Market Cap (Jan-05-2024)1.095 Billion USDWorld Rank (Jul-30-2023)7,713Market Cap (Jul-30-2023)1.232 Billion USDWorld Rank (Dec-25-2022)7,827Market Cap (Dec-25-2022)1.122 Billion USDWorld Rank (Jan-07-2022)7,318Market Cap (Jan-07-2022)1.54 Billion USDAnnual Revenue in USD2 Million USDAnnual Net Income in USD-157 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileVerve Therapeutics is the preeminent company developing gene editing medicines to treat patients with cardiovascular disease. The headquarters is in USA.Company Website -
MannKind Corporation
World Rank (Jan-05-2024)8,442Market Cap (Jan-05-2024)1.030 Billion USDWorld Rank (Jul-30-2023)7,743Market Cap (Jul-30-2023)1.224 Billion USDWorld Rank (Dec-25-2022)7,058Market Cap (Dec-25-2022)1.340 Billion USDWorld Rank (Jan-07-2022)9,303Market Cap (Jan-07-2022)1.02 Billion USDAnnual Revenue in USD100 Million USDAnnual Net Income in USD-87 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileMankind Corporation is a biopharmaceutical company with headquarters is in California, USA. It develops cutting-edge therapeutic products and technologies that help people take control of their health.Company WebsiteWikipedia -
Trupanion
World Rank (Jan-05-2024)7,709Market Cap (Jan-05-2024)1.201 Billion USDWorld Rank (Jul-30-2023)7,759Market Cap (Jul-30-2023)1.220 Billion USDWorld Rank (Dec-25-2022)5,445Market Cap (Dec-25-2022)2.003 Billion USDWorld Rank (Jan-07-2022)3,624Market Cap (Jan-07-2022)4.40 Billion USDAnnual Revenue in USD905 Million USDAnnual Net Income in USD-45 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileTrupanion has been taking care of pet owners for over a decade by offering simple, fair and affordable pet insurance. The headquarters is in USA.
Company Website